Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 1989

Procardia Xl(Nifedipine)Pfizer Inc. logoPFE

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Pfizer Inc.

$979K

Medicare cost, 2024

Medicare drug plans spent $978,592 on Procardia Xl (nifedipine) in 2024, for 1,214 prescriptions and refills filled by 396 patients. Spending fell 51% from 2023 to 2024. New York accounts for the most spending ($168,830, 17% of the total). It is made by Pfizer Inc. (PFE).

Medicare cost, 2024

$979K

-51.2% from 2023

Prescriptions

1,214

$806.09 per claim

Patients

396

469 prescribers

Total spending, 2024

$979K

$2,471.19 per patient

Questions and answers

How much does Medicare spend on Procardia Xl?

Medicare prescription drug plans paid $979K for Procardia Xl in 2024, for 1,214 prescriptions and refills to 396 patients (down 51.2% from 2023). The average cost per claim was $806.09.

Which state spends the most on Procardia Xl?

New York had the highest Medicare cost for Procardia Xl in 2024: $169K for 197 claims, followed by California ($110K).

Who prescribes Procardia Xl the most?

Ramon Rivera-Morales, family practice in Miami, FL, had the highest Medicare cost for Procardia Xl in 2024: 12 claims costing $4,997.

Who makes Procardia Xl?

Procardia Xl is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Procardia Xl was $979K in 2024, after a high of $3.0M in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Procardia Xl, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Ramon Rivera-Morales Miami, FLFamily Practice12Under 11$4,997
Alexander Bangiev Rego Park, NYNephrology17Under 11$4,238

Prescriber data by year

YearPrescribersClaimsPatientsCost
20228743,065728$2.2M
20237902,767652$2.0M
20244691,214396$979K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Pfizer US PharmPFE logoPFE1,214$979K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
5
Application numbers
NDA019684

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube